[go: up one dir, main page]

DE60010452D1 - Programmierte ovarielle stimulationsbehandlungprotokoll unter verwendung von oralen kontrazeptiva - Google Patents

Programmierte ovarielle stimulationsbehandlungprotokoll unter verwendung von oralen kontrazeptiva

Info

Publication number
DE60010452D1
DE60010452D1 DE60010452T DE60010452T DE60010452D1 DE 60010452 D1 DE60010452 D1 DE 60010452D1 DE 60010452 T DE60010452 T DE 60010452T DE 60010452 T DE60010452 T DE 60010452T DE 60010452 D1 DE60010452 D1 DE 60010452D1
Authority
DE
Germany
Prior art keywords
ovarial
programmed
treatment protocol
stimulation treatment
oral contraceptives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60010452T
Other languages
English (en)
Other versions
DE60010452T2 (de
Inventor
Juergen Engel
Hilde Riethmueller-Winzen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zentaris IVF GmbH
Original Assignee
Zentaris AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris AG filed Critical Zentaris AG
Publication of DE60010452D1 publication Critical patent/DE60010452D1/de
Application granted granted Critical
Publication of DE60010452T2 publication Critical patent/DE60010452T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60010452T 1999-03-31 2000-03-21 Programmierte ovarielle stimulationsbehandlungprotokoll unter verwendung von oralen kontrazeptiva Expired - Lifetime DE60010452T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12724199P 1999-03-31 1999-03-31
US127241P 1999-03-31
US13163299P 1999-04-28 1999-04-28
US131632P 1999-04-28
PCT/EP2000/002466 WO2000059542A1 (en) 1999-03-31 2000-03-21 Method for a programmed controlled ovarian stimulation protocol

Publications (2)

Publication Number Publication Date
DE60010452D1 true DE60010452D1 (de) 2004-06-09
DE60010452T2 DE60010452T2 (de) 2005-04-14

Family

ID=26825471

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60010452T Expired - Lifetime DE60010452T2 (de) 1999-03-31 2000-03-21 Programmierte ovarielle stimulationsbehandlungprotokoll unter verwendung von oralen kontrazeptiva

Country Status (28)

Country Link
US (1) US8173592B1 (de)
EP (1) EP1165138B1 (de)
JP (1) JP4616999B2 (de)
KR (1) KR100679880B1 (de)
CN (1) CN1346281B (de)
AR (1) AR023249A1 (de)
AT (1) ATE265862T1 (de)
AU (1) AU768544B2 (de)
BG (1) BG65270B1 (de)
BR (1) BR0009477A (de)
CA (1) CA2367214C (de)
CO (1) CO4970741A1 (de)
CZ (1) CZ299820B6 (de)
DE (1) DE60010452T2 (de)
DK (1) DK1165138T3 (de)
ES (1) ES2219331T3 (de)
HK (1) HK1044892B (de)
HU (1) HU229252B1 (de)
IL (2) IL145630A0 (de)
MX (1) MXPA01009862A (de)
NO (1) NO327210B1 (de)
NZ (1) NZ514964A (de)
PL (1) PL199569B1 (de)
PT (1) PT1165138E (de)
RU (1) RU2226395C2 (de)
SK (1) SK287244B6 (de)
TW (1) TWI241194B (de)
WO (1) WO2000059542A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788799A3 (de) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagoniste für Behandlung von Fruchtbarkeitsstörungen
SI1594483T1 (sl) 2003-02-21 2006-12-31 Schering Ag UV-stabilni transdermalni terapevtski obliz
US8668925B2 (en) * 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
EP1719504A1 (de) * 2005-05-02 2006-11-08 Schering AG Festes transdermales therapeutisches System mit UV-Absorber
WO2007011072A1 (ja) * 2005-07-22 2007-01-25 Takeda Pharmaceutical Company Limited 早発排卵の防止剤
US9585854B2 (en) * 2012-11-09 2017-03-07 Iasomai Ab N-acetyl-L-cysteine for use in in vitro fertilization
JP6841753B2 (ja) 2014-09-15 2021-03-10 ザ チルドレンズ メディカル センター コーポレーション ヒストンｈ３−リジントリメチル化を除去することによって体細胞核移入（ｓｃｎｔ）効率を増加させるための方法および組成物
EP3662925B1 (de) * 2015-04-17 2021-04-07 Ferring B.V. Zusammensetzung enthaltend fsh zur behandlung von unfruchtbarkeit
AU2017336338B2 (en) 2016-09-30 2022-11-10 Sumitomo Pharma Switzerland Gmbh Methods of treating female infertility
RU2665967C1 (ru) * 2017-06-14 2018-09-05 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ стимуляции роста фолликулов в программах экстракорпорального оплодотворения у пациенток с бесплодием различного генеза и "бедным ответом на стимуляцию"
CN107982520A (zh) * 2017-12-25 2018-05-04 上海交通大学医学院附属第九人民医院 外源性MPA与hMG在制备动物模型药物中的应用
CN110570952B (zh) * 2018-06-05 2022-04-12 北京大学第三医院 预测拮抗剂方案下受试者卵巢低反应概率的系统及指导促性腺激素起始用药剂量选择的系统
CN110491505B (zh) * 2019-08-22 2021-06-01 北京大学第三医院（北京大学第三临床医学院） 预测受试者卵巢刺激过程中获得的卵母细胞数量的系统
CN113456801A (zh) * 2021-08-05 2021-10-01 浙江大学医学院附属第四医院 人绒毛膜促性腺激素在制备早发性卵巢功能不全患者的助孕药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016259A (en) * 1974-07-26 1977-04-05 Research Corporation Contraceptive polypeptides
JPS6176421A (ja) * 1984-04-03 1986-04-18 セロノ　ラボラトリ−ズ　インコ−ポレイテツド 排卵誘発方法およびインビトロ受精方法
ZA901847B (en) 1989-03-10 1991-10-30 Endorecherche Inc Combination therapy for the treatment of estrogen sensitive diseases
US5470847A (en) * 1993-12-10 1995-11-28 Board Of Regents, The University Of Texas System Ovulation control by regulating nitric oxide levels with arginine derivatives
MX9700574A (es) 1994-07-22 1997-12-31 Hampton Roads Medical College Metodo para establecer la secrecion de estrogeno tonico ovarico para regimenes terapeuticos prolongados.
EP0788799A3 (de) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagoniste für Behandlung von Fruchtbarkeitsstörungen
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
CA2200541C (en) 1997-01-22 2013-02-19 Philippe Bouchard Lhrh-antagonists in the treatment of fertility disorders
AU4325797A (en) * 1997-06-23 1999-01-04 Mcneil-Ppc, Inc. Acetaminophen and cisapride analgesics
WO1999055357A1 (en) * 1998-04-23 1999-11-04 Asta Medica Aktiengesellschaft Method for the treatment of fertility disorders

Also Published As

Publication number Publication date
MXPA01009862A (es) 2003-10-14
WO2000059542A9 (en) 2001-11-22
BR0009477A (pt) 2002-01-08
NO327210B1 (no) 2009-05-11
NO20014736L (no) 2001-11-26
CN1346281A (zh) 2002-04-24
PL199569B1 (pl) 2008-10-31
JP2002541122A (ja) 2002-12-03
US8173592B1 (en) 2012-05-08
CZ299820B6 (cs) 2008-12-03
CA2367214A1 (en) 2000-10-12
HU229252B1 (en) 2013-10-28
AU768544B2 (en) 2003-12-18
PT1165138E (pt) 2004-09-30
HK1044892B (zh) 2011-06-30
SK13842001A3 (sk) 2002-09-10
DK1165138T3 (da) 2004-08-30
ES2219331T3 (es) 2004-12-01
CO4970741A1 (es) 2000-11-07
CN1346281B (zh) 2010-04-14
BG106045A (en) 2002-05-31
WO2000059542A1 (en) 2000-10-12
KR20010105401A (ko) 2001-11-28
HK1044892A1 (en) 2002-11-08
PL351327A1 (en) 2003-04-07
DE60010452T2 (de) 2005-04-14
SK287244B6 (sk) 2010-04-07
RU2226395C2 (ru) 2004-04-10
NZ514964A (en) 2003-08-29
HUP0200431A3 (en) 2004-04-28
CZ20013495A3 (cs) 2002-06-12
BG65270B1 (bg) 2007-11-30
TWI241194B (en) 2005-10-11
EP1165138A1 (de) 2002-01-02
HUP0200431A2 (hu) 2002-07-29
JP4616999B2 (ja) 2011-01-19
IL145630A (en) 2009-09-01
ATE265862T1 (de) 2004-05-15
NO20014736D0 (no) 2001-09-28
AR023249A1 (es) 2002-09-04
AU4106900A (en) 2000-10-23
EP1165138B1 (de) 2004-05-06
KR100679880B1 (ko) 2007-02-07
IL145630A0 (en) 2002-06-30
CA2367214C (en) 2008-07-29

Similar Documents

Publication Publication Date Title
DE60124021D1 (de) Implantierbare Stimulationsleitung
DE60108581D1 (de) Implantierbarer Herzschrittmacher
DE60010452D1 (de) Programmierte ovarielle stimulationsbehandlungprotokoll unter verwendung von oralen kontrazeptiva
DE59711759D1 (de) Ratenadaptiver Herzschrittmacher
DE50010727D1 (de) Flächiges Implantat
DE69916691D1 (de) Herzschrittmacher
DE60042252D1 (de) Implantierbare medizinische Vorrichtung
DE69939068D1 (de) Entfernbare implantierbare medizinische leitung
DE59810269D1 (de) Selbstkalibrierender ratenadaptiver Herzschrittmacher
EP1202693A4 (de) Cochleare implantatverpackung
DE60017816D1 (de) Herzschrittmacher
DE60105989D1 (de) Implantierbarer herzstimulator
DK1223887T3 (da) Implantatindstilling
DE60016600D1 (de) Herzschrittmacher
DE59911113D1 (de) Herzschrittmacher
DE69818638D1 (de) Zahnmedizinisches implantat
IT1293832B1 (it) Impianto dentale osteointegrato
BR0212808A2 (pt) Loção capilar estimulante do crescimento dos cabelos
DE69916133D1 (de) Elektro-neuro-adaptiver stimulator
DE59900924D1 (de) Selbstkalibrierender ratenadaptiver Herzschrittmacher
DE60013608D1 (de) Herzschrittmacher
ITMI991641A0 (it) Dispositivo per impianto dentale
DE59812444D1 (de) Ratenadaptiver Herzschrittmacher
DE60016452D1 (de) Herzschrittmacher
DE60016737D1 (de) Implantierbarer herzschrittmacher

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AETERNA ZENTARIS GMBH, 60314 FRANKFURT, DE

8327 Change in the person/name/address of the patent owner

Owner name: ZENTARIS IVF GMBH, 60314 FRANKFURT, DE